ArticleBMC cancer2023

Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose.

Ying-Ying Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.